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A number of early investigations suggest
that hair follicles and sebaceous glands are
important in epidermal carcinogenesis. Lascas-
sagne and Lata.rjet observed that tumors de-
velop in regions of scar tissue only where hair
follicles and sebaceous glands persist (1). Sunt-
zeff et al. (2) failed to observe carcinomas be-
fore the development of mature hair follicles
and sebaceous glands in newborn mice and also
report a close correlation between the destruc-
tion of sebaceous glands and chemical carci-
nogeneic potency (3). In other studies, hydro-
carbons have been reported to induce skin
tumors without prior destruction of sebaceous
glands (4, 5). These latter observations make
the central role of the sebaceous gland in tumor
induction less certain.
In order to better understand the role of
the pilosebaceous unit in tumorigenesis, we have
studied the development of carcinomas in a
group of mutant mice characterized by specific
defects in the pilosebaceous unit. This report
is a description of the incidence, morphology,
and histology of tumors induced by 7,12-
dimethylbenzanthracene (DMBA) in normal,
hairless, asebic, and hairless-asebic mutant
stocks of mice.
MATERIALS AND METHODS
Four stocks of mice, each differing in their
pilosebaeeous units, were used in the present
study. The normal mice were F1 hybrid females ob-
tained from a cross of the strains BALB/cGa and
129/RrGa. The first mutant group, homozygous
for hairlessness, was obtained from the Jackson
Laboratory. The second mutant group, homo-
zygous for asebia, was obtained from the inbred
colony BALB/eGa—+ab maintained in our labo-
ratory (6). The third mutant group, homozygous
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for both hairlessness and asebia, was bred and
maintained in our laboratory as described in the
report by Gates, Arundell, and Karasek (7).
There were 24 mice in the normal group, 12 in
the hairless, 19 in the hairless-asebic, and 17 in
the asebic. All of the normal mice were females.
Each of the hairless, hairless-asebic, and asebic
groups of mice contained both males and females.
The ages in each group ranged from 6 to 10
months. All of the animals were maintained on an
ad libitum standard laboratory diet of Purina
chow and water.
Each treated animal received two applications
of 0.1 ml of 0.50% DMBA in acetone on the
shaved midback region at a one week interval.
Because of the severity of the inflammation cre-
ated by 0.5% DMBA no carcinogen was applied
for one week. Weekly applications of 0.1 ml of
0.25% DMBA in acetone were resumed in the
fourth week of the study and were continued un-
til the ninth week. Each treated animal received
a total dose of 2500 micrograms of DMBA topi-
cally. Two control animals in each group received
only placebo applications of acetone during the
same time period.
Observation of the animals was continued at
weekly intervals for a total of 8 months. Photo-
graphs and biopsies of representative cutaneous
lesions were obtained. Autopsies were performed
on mice with large invasive tumors. The tissues
were fixed in buffered formalin. Sections were
prepared with hematoxylin and eosin, periodic
acid-Schiff, toluidine blue, colloidal iron and luxol
fast blue stains (8).
RESULTS
Early Changes. Dermatitis developed in all
treated animals after the first application of
DMBA. The severity of the dermatitis dimin-
ished with each succeeding application of
DMBA. The epidermal changes included hyper-
keratosis, spongiosis, intracellular edema, and
subepidermal vesicles. Edema extended into
the follicles in the normal and asebic animals
and into tile remnants of hair follicles in the
hairless and hairless-asebic mice. The sebaceons
glands were destroyed in the normal and hair-
less mice. The dermis in all groups showed
edema, focal homogenization of collagen, and
an inflammatory infiltrate. Necrosis and in-
flammatory cells were present in the siibcuta-
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FIG. 1. Histologic changes in the skin after 3 applications of DMBA. A. Normal. B.
Hairless. C. Hairless-asebic. D. Asebic. (H & E, X 103.)
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Fio. 2. Histologic changes in premalignant papillomas 5 weeks after the initial applica-
tion of DMBA. A. Normal. B. Hairless. C. Hairless-asebic. D. Asebic. (H & E, )< 103.)
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TABLE I
Incidence of Squamous Cell Carcinoma
Number of DMBA- Number of mire
Type of mouse treatrd survivors
(>10 weeks)
with squamous
rd1 rarriooma
Normal 22 9
Hairless 10 4
Hairless-asebic 8 3
Asebic 14 3
neous fat. Special stains showed an intact base-
ment membrane. degeneration of collagen,
and an increase of acid mucopolysaccharides
in the dermis and subcutaneous fat.
Pale, sclerotic plaques developed in the
treated areas after the third application and
persisted throughout the study. Regeneration
of hair follicles in the normal and ascbic mice
and regeneration of sebaccous glands in the
normal and hairless mice occurred in the third
to fifth week of the study. The microscopic
changes present in the plaques are shown in
Figure 1. These changes were characterized by
increasing epidermal hyperplasia and dermal
fibrosis and decreasing edema and inflam-
matory infiltrate. Epidermal hyperplasia was
more pronounced in the normal and hairless-
asebic than in the hairless and asebic mice.
Premalignant Papillomas. Multiple ver-
rucous papillomas appeared in the treated
areas and in adjacent untreated areas in the
fifth week. All of the DMBA-trcated ascbic,
normal, hairless, and hairless-ascbic mice de-
veloped premalignant warty papillomas by the
ninth week of the study. The asebic mice
developed fewer papillomas per mouse (aver-
age 7) than the other groups of mice (average
15). Spontaneous regression of the papillomas
began in the third month in the asebic mice
and in the seventh month in the other groups.
In all groups of mice, the vcrrucous papil-
lomas which persisted, coalesced to form large
warty plaques. No papillomas developed in
the control animals.
Microscopic changes in the verrucous papil-
lomas from the four groups of mice arc shown
in Figure 2. The epidermis showed the typical
premalignant changes found in warty papules
induced by the topical application of carci-
nogens (9). Frequent mitotic figures, nuclear
hyperchromasia, and intercellular separation
were present in the acanthotic papillomatous
lesions. In the biopsies of verrucous papillomas
obtained at monthly intervals following their
initial appearance, acanthosis and papillomato-
sis increased and replacement of large areas
of the epidermis by atypical epidermal cells
occurred.
Squamous Cell Carcinomas. After the third
month, central ulceration and crusting occurred
in the large warty plaques in each of the four
groups of mice. The borders of the ulcerated
areas became elevated and deeply infiltrative.
Squamous cell carcinomas were noted in the
third month in the normal, hairless, and hair-
less-asebic mice and in the fifth month in the
asebic mice. All of the squamous cell carci-
nomas which developed arose from prc-exist-
ing papillomas. No squamous cell carcinomas
developed in the control animals.
Invasion of the entire depth of the dermis
and penetration of the panniculus carnosus
were used as the criteria for the classification
of squamous cell carcinoma. The incidence of
squamous cell carcinomas in the treated mice
surviving beyond the tenth week of the study
is shown in Table I. Squamous cell carcinomas
were found in 9 of 22 normal mice, 4 of 10
hairless mice, 3 of 8 hairless-asebic mice, and
3 of 14 asebic mice. These differences in in-
cidence arc not significant (p < 0.10). Al-
though the degree of differentiation varied
from tumor to tumor, there was no correla-
tion between the degree of anaplasia and any
single group of mice.
Others Tumors. In addition to squamous cell
carcinomas, other benign and malignant tu-
mors were noted in the treated animals.
These tumors included two angiomas, three
fibrosarcomas, and one lymphoma in normal
mice; one myxosarcoma in an asebic mouse;
and one lymph-angioma in a hairless mouse.
No adnexal carcinomas or basal cell carci-
nomas developed in the treated animals dur-
ing the 8 months of the study.
DISCUSSION
The three stocks of mutant mice used in the
present studies show marked differences in
skin metabolism and physiology. All of the
mutants arc retarded in growth and have a
reduced fertility (6, 7). Although the adult
mutants have either no hair growth (hairless,
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hairless-asebie), or a greatly reduced hair
growth (asebic), the skin of all of the adult
mutants always shows remnants of hair fol-
licles. The asehic mice, in addition to their
specific mutations in the pilosebaceous units,
are deficient in sterols esterified with long-
chain fatty acids, wax esters, and wax diesters,
as a result of defective fatty acid metabolism
in the skin epithelial cell (10). Because of
these marked differences in the skin physiol-
ogy and metabolism and the unknown effects
of such differences on the reactivity of the
skin to carcinogens, it is surprising that each
of the three mutants developed squamous cell
carcinomas within 5 months after the initiation
of DMBA treatment. The only detectable
differences are minor changes in the degree of
hyperplasia between the stocks (Fig. 1). The
development of cutaneous squamous cell carci-
nomas in mutant mice with congenital ab-
sence of sebaceous glands indicates that se-
baceous glands do not play a critical role in
DMBA-induccd squamous cell carcinoma.
SUMMARY
Squamous cell carcinomas were induced by
topical applications of DMBA in three groups
of mutant mice characterized by specific de-
fects of the pilosebaccous units. This study
shows that the presence of sebaccous glands
is not necessary for DMBA-induccd squamous
cell carcinomas in mouse skin.
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